glp-1 semaglutide and tirzepatide & are transforming diabetes & obesity management. These receptor agonists offer benefits from glycemic control to weight loss cardiovascular risk reduction, emphasizing their broad impact. Read more from Semaglutide vs. Tirzepatide: How Weight-Loss

We created our NSF certified probiotic with bacterial strains which are known to help with glucose resistance

Esa combinacin permite estudiar en un solo modelo seales relacionadas con respuesta a la glucosa, saciedad, movilizacin de sustratos y gasto energtico

Your provider will determine whether tirzepatide is suitable for you based on your medical profile

Interested parties can learn more at Roughly 1 in 8 American adults are taking GLP-1 drugs like Ozempic or Wegovy to lose weight or treat a chronic condition, according to data from the Kaiser Family Foundation

Large glucose swings, visceral adiposity, fatty liver, and elevated fasting insulin may all signal a metabolic environment that is less favorable for long-term cognitive health